However, it is now well known that many WHO grade II and grade III IDH‐wt diffuse gliomas not only have molecular characteristics of, but also show clinical behavior of glioblastoma (WHO grade IV) (Cancer Genome Atlas Research Network et al., 2015). This evidence concerns the gene IDH1 and glioblastoma.